Jacques Tébib

4.2k total citations
91 papers, 2.3k citations indexed

About

Jacques Tébib is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jacques Tébib has authored 91 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Rheumatology, 19 papers in Immunology and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jacques Tébib's work include Rheumatoid Arthritis Research and Therapies (45 papers), Spondyloarthritis Studies and Treatments (19 papers) and Systemic Lupus Erythematosus Research (17 papers). Jacques Tébib is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (45 papers), Spondyloarthritis Studies and Treatments (19 papers) and Systemic Lupus Erythematosus Research (17 papers). Jacques Tébib collaborates with scholars based in France, Switzerland and United States. Jacques Tébib's co-authors include Xavier Le Loët, Fabienne Coury, Bernard Combe, Jean Sibilia, Aymeric Rivollier, Chantal Rabourdin‐Combe, Xavier Mariette, Maxime Dougados, M. Mazzorana and Pierre Jurdic and has published in prestigious journals such as Nature Medicine, Blood and PLoS ONE.

In The Last Decade

Jacques Tébib

84 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacques Tébib France 25 1.3k 669 402 386 272 91 2.3k
Matija Tomšič Slovenia 28 1.7k 1.3× 627 0.9× 318 0.8× 606 1.6× 192 0.7× 131 2.8k
Gaye Cunnane Ireland 28 1.3k 1.0× 496 0.7× 448 1.1× 361 0.9× 206 0.8× 59 2.2k
Serena Bugatti Italy 28 1.3k 1.0× 655 1.0× 258 0.6× 301 0.8× 289 1.1× 89 2.1k
Jonathan S. Coblyn United States 21 1.2k 0.9× 443 0.7× 199 0.5× 466 1.2× 147 0.5× 34 2.1k
Zhuoli Zhang China 27 1.1k 0.8× 563 0.8× 230 0.6× 228 0.6× 290 1.1× 141 2.3k
Scott W. Baumgartner United States 16 1.4k 1.0× 766 1.1× 343 0.9× 1.0k 2.6× 255 0.9× 18 2.5k
Xinping Tian China 27 1.6k 1.2× 774 1.2× 292 0.7× 398 1.0× 128 0.5× 214 2.8k
Olivier Vittecoq France 36 2.0k 1.5× 776 1.2× 581 1.4× 547 1.4× 266 1.0× 165 3.5k
Rolf Rau Germany 23 2.4k 1.8× 770 1.2× 405 1.0× 963 2.5× 298 1.1× 39 3.3k
Heikki Julkunen Finland 29 1.8k 1.4× 1.1k 1.7× 218 0.5× 327 0.8× 265 1.0× 88 2.6k

Countries citing papers authored by Jacques Tébib

Since Specialization
Citations

This map shows the geographic impact of Jacques Tébib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Tébib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Tébib more than expected).

Fields of papers citing papers by Jacques Tébib

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Tébib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Tébib. The network helps show where Jacques Tébib may publish in the future.

Co-authorship network of co-authors of Jacques Tébib

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Tébib. A scholar is included among the top collaborators of Jacques Tébib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Tébib. Jacques Tébib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tatar, Zuzana, Carole Migné, Mélanie Pétéra, et al.. (2016). Variations in the metabolome in response to disease activity of rheumatoid arthritis. BMC Musculoskeletal Disorders. 17(1). 353–353. 24 indexed citations
2.
Coury, Fabienne, et al.. (2016). Fibromyalgia in Spondyloarthritis: Effect on Disease Activity Assessment in Clinical Practice. The Journal of Rheumatology. 43(11). 2056–2063. 52 indexed citations
3.
Tébib, Jacques, et al.. (2014). Atypical focal forms of Whipple's disease seen by rheumatologists. Joint Bone Spine. 82(1). 56–59. 8 indexed citations
4.
Janoly-Duménil, A., et al.. (2013). OP0286 Effects of an Educational Program on the Safety Knowledge and Skills of Patients with Rheumatoid Arthritis Treated by Biologics. Annals of the Rheumatic Diseases. 72. A150–A151. 1 indexed citations
5.
Fantino, Bruno, et al.. (2012). Diagnostic et prise en charge thérapeutique de la polyarthrite rhumatoïde en Rhône-Alpes : une enquête « vraie vie » en 2010. Revue du Rhumatisme. 80(2). 130–135. 1 indexed citations
6.
Sellam, Jérémie, Houria Hendel‐Chavez, Stéphanie Rouanet, et al.. (2011). B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: A six‐month, national, multicenter, open‐label study. Arthritis & Rheumatism. 63(4). 933–938. 118 indexed citations
7.
Dernis, Emmanuelle, Adeline Ruyssen‐Witrand, Gaël Mouterde, et al.. (2010). Use of glucocorticoids in rheumatoid arthritis – Pratical modalities of glucocorticoid therapy: Recommendations for clinical practice based on data from the literature and expert opinion. Joint Bone Spine. 77(5). 451–457. 24 indexed citations
8.
Bouysset, M., Fabienne Coury, T. Tavernier, et al.. (2009). Traitement par adalimubab d’une arthrite de cheville et d’une tarsite dans la spondylarthropathie psoriasique. 1 indexed citations
9.
10.
Coury, Fabienne, Nicola Annels, Aymeric Rivollier, et al.. (2007). Langerhans cell histiocytosis reveals a new IL-17A–dependent pathway of dendritic cell fusion. Nature Medicine. 14(1). 81–87. 155 indexed citations
11.
Becchi, Michel, et al.. (2007). A New Target for Autoantibodies in Patients with Rheumatoid Arthritis. Annals of the New York Academy of Sciences. 1108(1). 382–391. 7 indexed citations
12.
Marotte, Hubert, Béatrice Pallot-Pradès, Laurent Grange, et al.. (2005). The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population. Annals of the Rheumatic Diseases. 65(3). 342–347. 60 indexed citations
13.
Ferraro‐Peyret, Carole, et al.. (2002). Improvement in diagnosis of rheumatoid arthritis using dual indirect immunofluorescence and immunoblotting assays for antifilaggrin autoantibodies: a retrospective 3 year study.. PubMed. 29(2). 276–81. 4 indexed citations
14.
Maillefert, Jean Francis, C Tavernier, & Jacques Tébib. (2000). Determining the site of the primary cancer in patients with skeletal metastasis of unknown origin. Cancer. 88(7). 1759–1760.
15.
Combe, Bernard, Philippe Goupille, J.-L. Kuntz, et al.. (1996). SULPHASALAZINE IN PSORIATIC ARTHRITIS: A RANDOMIZED, MULTICENTRE, PLACEBO-CONTROLLED STUDY. Lara D. Veeken. 35(7). 664–668. 75 indexed citations
16.
Bouysset, M., T. Tavernier, Jacques Tébib, et al.. (1995). CT and MRI evaluation of tenosynovitis of the rheumatoid hindfoot. Clinical Rheumatology. 14(3). 303–307. 23 indexed citations
17.
Tébib, Jacques, et al.. (1992). Imagerie par résonance magnétique nucléaire et rhumatologie. Clinical Rheumatology. 11(4). 507–507.
18.
Tébib, Jacques, et al.. (1992). Serum N terminal procollagen III fragment: A predictive marker of joint destruction in rheumatoid arthritis?. Clinical Rheumatology. 11(4). 502–507. 6 indexed citations
19.
Bouysset, M., Jacques Tébib, É. Noël, et al.. (1989). The rheumatoid heel: Its relationship to other disorders in the rheumatoid foot. Clinical Rheumatology. 8(2). 208–214. 7 indexed citations
20.
Bouysset, M., et al.. (1987). Deformation of the adult rheumatoid rearfoot. A radiographic study. Clinical Rheumatology. 6(4). 539–544. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matija Tomšič Breakdown of academic impact, for papers by Gaye Cunnane Breakdown of academic impact, for papers by Serena Bugatti Breakdown of academic impact, for papers by Jonathan S. Coblyn Breakdown of academic impact, for papers by Zhuoli Zhang Breakdown of academic impact, for papers by Scott W. Baumgartner Breakdown of academic impact, for papers by Xinping Tian Breakdown of academic impact, for papers by Olivier Vittecoq Breakdown of academic impact, for papers by Rolf Rau Breakdown of academic impact, for papers by Heikki Julkunen
Rankless by CCL
2026